首页> 外国专利> Process for the manufacture of alkali salts, slightly soluble or less soluble heterocycles of sulfinila substituu00ecda, pharmaceutical dosage form, the use of the same.Method of treatment of gastrointestinal diseases, and process for the manufacture of a pharmaceutical dosage form.

Process for the manufacture of alkali salts, slightly soluble or less soluble heterocycles of sulfinila substituu00ecda, pharmaceutical dosage form, the use of the same.Method of treatment of gastrointestinal diseases, and process for the manufacture of a pharmaceutical dosage form.

机译:碱金属盐,亚磺胺取代基的难溶性或难溶性杂环的制备方法,药物剂型,其用途,治疗胃肠道疾病的方法以及药物剂型的制备方法。

摘要

Process for the manufacturing of slightly soluble or less soluble alkaline salts of substituted sulphinyl heterocycles containing an imidazole moiety with formula Ipreferably alkaline salts of a proton pump inhibitor compound, wherein the process comprises the step of reacting the substituted sulphinyl heterocycle of Formula I with a source of the cation in the presence of a base, characterized by a washing step in which the prepared alkaline salt of the substituted sulphinyl compound is washed with a basic aqueous solvent mixture. The obtained bulk drug substance resulting in a bulk product that in an aqueous suspension of the substituted sulphinyl heterocycle having a pH not significantly lower than that of a saturated water solution of the pure compound prepared. Alternatively, the process for manufacturing a pharmaceutical dosage form comprising the active substance could be adjusted. For instance the pH of an aqueous suspension of the active substance is adjusted to a pH not significantly lower than that of a saturated water solution of the pure compound. The processes are preferably useful in the manufacturing of omeprazole magnesium salt or magnesium salt of one of its single enantiomers used in pharmaceutical dosage forms.
机译:用于制备具有咪唑基的具有式I,优选质子泵抑制剂化合物的碱金属盐的,含有咪唑基的取代的亚磺酰基杂环的略溶或难溶的碱性盐的制备方法,其中该方法包括使式I的取代的亚磺酰基杂环与源反应的步骤在碱的存在下进行阳离子交换的步骤,其特征在于洗涤步骤,其中用碱性含水溶剂混合物洗涤所制备的取代的亚磺酰基化合物的碱性盐。得到的原料药得到的原料药在取代的亚磺酰基杂环的水悬浮液中的pH值不明显低于所制备的纯化合物的饱和水溶液的pH值。可替代地,可以调节用于制造包含活性物质的药物剂型的方法。例如,将活性物质的水悬浮液的pH调节至不明显低于纯化合物的饱和水溶液的pH。该方法优选用于生产奥美拉唑镁盐或用于药物剂型的其单一对映体之一的镁盐。

著录项

  • 公开/公告号NO321275B1

    专利类型

  • 公开/公告日2006-04-10

    原文格式PDF

  • 申请/专利权人 ASTRAZENECA AB;

    申请/专利号NO20010002427

  • 申请日2001-05-16

  • 分类号C07D401/12;A61K9/16;A61K31/4439;A61P1/04;A61P1/14;A61P17;A61P29;A61P35;

  • 国家 NO

  • 入库时间 2022-08-21 21:38:06

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号